Suzhou Zelgen Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 97.08x

Suzhou Zelgen Biopharmaceuticals Co Ltd cash flow reinvestment rate. Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Cash Flow Reinvestment Rate of 97.08x as of September 2025, reinvesting CN¥52.78 Million (capex CN¥52.78 Million ) from operating cash flow of CN¥543.69K. Explore Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

97.08x

(Capex + Investments) / Operating CF

Total Reinvested

CN¥52.78 Million

Capex + Investments

Operating Cash Flow

CN¥543.69K

CNY

Capital Expenditures

CN¥52.78 Million

CNY

Cash Flow Reinvestment Rate of Suzhou Zelgen Biopharmaceuticals Co Ltd (2024–2024)

Cash flow reinvestment rate of Suzhou Zelgen Biopharmaceuticals Co Ltd from 2024 to 2024. Historical reinvestment intensity for Suzhou Zelgen Biopharmaceuticals Co Ltd across 1 annual periods. Explore 688266 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Suzhou Zelgen Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate by Year (2024–2024)

Suzhou Zelgen Biopharmaceuticals Co Ltd cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Suzhou Zelgen Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Suzhou Zelgen Biopharmaceuticals Co Ltd cash conversion from operations.

Year	Reinvestment Rate	Total Reinvested (CNY)	Operating CF	Capex	YoY Change
2024	48.30x	CN¥1.85 Billion	CN¥38.20 Million	CN¥95.69 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow